REGISTERED NUMBER: 06818759 (England and Wales)

Financial Statements for the Year Ended 28 February 2025

for

Thurmaston Pharmacy Limited

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

4

DIRECTOR:

Mr Jalkesh Amin

REGISTERED OFFICE:

721 Melton Road

Thurmaston

Leicestershire

LE4 8ED

REGISTERED NUMBER:

06818759 (England and Wales)

ACCOUNTANTS:

Sterling Accounting Services Limited

Bridge House

9-13 Holbrook Lane

Coventry

CV6 4AD

FIXED ASSETS

Intangible assets

4

-

-

Property, plant and equipment

5

8,835

10,710

8,835

10,710

CURRENT ASSETS

Inventories

17,403

16,511

Debtors

6

135,158

155,216

Cash at bank and in hand

22,128

15,022

174,689

186,749

CREDITORS

Amounts falling due within one year

7

107,008

130,183

NET CURRENT ASSETS

67,681

56,566

TOTAL ASSETS LESS CURRENT LIABILITIES

76,516

67,276

CREDITORS

Amounts falling due after more than one year

8

(32,383

)

(38,070

)

PROVISIONS FOR LIABILITIES

(2,180

)

(2,180

)

NET ASSETS

41,953

27,026

CAPITAL AND RESERVES

Called up share capital

9

100

100

Retained earnings

41,853

26,926

SHAREHOLDERS' FUNDS

41,953

27,026

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 October 2025 and were signed by:

Mr Jalkesh Amin - Director

1.	STATUTORY INFORMATION

Thurmaston Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

20% on reducing balance

Stocks

Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2024 - 8 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 March 2024

and 28 February 2025

3,201

AMORTISATION

At 1 March 2024

and 28 February 2025

3,201

NET BOOK VALUE

At 28 February 2025

-

At 29 February 2024

-

5.	PROPERTY, PLANT AND EQUIPMENT

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 March 2024

and 28 February 2025

823

35,905

36,728

DEPRECIATION

At 1 March 2024

823

25,195

26,018

Charge for year

-

1,875

1,875

At 28 February 2025

823

27,070

27,893

NET BOOK VALUE

At 28 February 2025

-

8,835

8,835

At 29 February 2024

-

10,710

10,710

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

28.2.25

29.2.24

£

£

Trade debtors

123,610

141,904

Other debtors

11,548

13,312

135,158

155,216

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

28.2.25

29.2.24

£

£

Trade creditors

58,783

75,262

Taxation and social security

14,071

10,754

Other creditors

34,154

44,167

107,008

130,183

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

28.2.25

29.2.24

£

£

Bank loans

32,383

38,070

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

28.2.25

29.2.24

value:

£

£

100

Ordinary

£1

100

100

10.	RELATED PARTY DISCLOSURES

J H Amin Limited is the holding company of Thurmaston Pharmacy Limited and during the year

1) The company paid a dividend to J H Amin Limited in the sum of £18,000..

2) The Company paid a commercial management charge of £35,000 to J H Amin Limited.

The Net amount to J H Amin Limited at 28 February 2025 was £53,000.

11.	ULTIMATE CONTROLLING PARTY

The immediate and ultimate parent undertaking is J H Amin Limited which is registered in England and Wales.